Anti-BACE2 [1/ 9 ]
AB00481-10.6-BT
ApplicationsWestern Blot, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetBACE2
Overview
- SupplierAbsolute Antibody
- Product NameAnti-BACE2 [1/ 9 ]
- Delivery Days Customer9
- Application Supplier NoteThe antibody binds specifically to BACE2, an enzyme responsible for the proteolytic cleavage of amyloid precursor protein (APP). The protein is cleaved between residues 690 and 691, leading to the formation of beta-cleaved soluble APP and a C-terminal membrane bound fragment (CTFbeta). The latter is then cleaved by gamma-secretase to generate amyloid beta peptide. BACE is the rate-limiting enzyme in the pathway, and is a potential target in the treatment of Alzheimers Disease (AD),a neurodegenerative disorder characterised by amyloid beta plaques within the brain. The BACE2 protein is encoded in chromosome 21, in a region critical for the development of Downs Syndrome, and may play a role in the amyloid beta deposition in the disease.
- ApplicationsWestern Blot, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID1/ 9
- Gene ID25825
- Target nameBACE2
- Target descriptionbeta-secretase 2
- Target synonyms56 kDa aspartic-like protease; AEPLC; ALP56; ASP1; ASP21; aspartyl protease 1; BAE2; beta-secretase 2; beta-site amyloid beta A4 precursor protein-cleaving enzyme 2; beta-site APP-cleaving enzyme 2; CDA13; CEAP1; Down syndrome region aspartic protease; DRAP; memapsin-1; membrane-associated aspartic protease 1; SLCO3A1/BACE2 fusion; theta-secretase; transmembrane aspartic proteinase Asp1
- HostHuman
- Protein IDQ9Y5Z0
- Protein NameBeta-secretase 2
- Scientific DescriptionThis chimeric human antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203